These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24853648)

  • 1. The effect of TC14012 on alkali burn-induced corneal neovascularization in mice.
    Shen M; Yuan F; Jin J; Yuan Y
    Ophthalmic Res; 2014; 52(1):17-24. PubMed ID: 24853648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats.
    Sari ES; Yazici A; Aksit H; Yay A; Sahin G; Yildiz O; Ermis SS; Seyrek K; Yalcin B
    Curr Eye Res; 2015 Jan; 40(1):48-55. PubMed ID: 24910898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects.
    Su W; Li Z; Li Y; Lin M; Yao L; Liu Y; He Z; Wu C; Liang D
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9108-15. PubMed ID: 22039247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of canstatin in alkali burn-induced corneal neovascularization.
    Wang Y; Yin H; Chen P; Xie L; Wang Y
    Ophthalmic Res; 2011; 46(2):66-72. PubMed ID: 21242701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.
    Zhou AY; Bai YJ; Zhao M; Yu WZ; Li XX
    Ophthalmic Res; 2013; 50(3):180-6. PubMed ID: 24008241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
    Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1.
    Zhou SY; Xie ZL; Xiao O; Yang XR; Heng BC; Sato Y
    Mol Vis; 2010 Jul; 16():1389-98. PubMed ID: 20680097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetramethylpyrazine in a Murine Alkali-Burn Model Blocks NFκB/NRF-1/CXCR4-Signaling-Induced Corneal Neovascularization.
    Tang M; Yang Y; Yu J; Qiu J; Chen P; Wu Y; Wang Q; Xu Z; Ge J; Yu K; Zhuang J
    Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):2133-2141. PubMed ID: 29801148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist.
    Lu P; Li L; Liu G; Zhang X; Mukaida N
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4761-8. PubMed ID: 19458323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effect of different concentrations of KH902 eye drops on corneal neovascularization induced by alkali burn.
    Wu Y; Xue C; Lu Y; Huang Z
    Indian J Ophthalmol; 2017 Nov; 65(11):1127-1132. PubMed ID: 29133637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The wound healing effects of vitamin A eye drops after a corneal alkali burn in rats.
    Kim EC; Kim TK; Park SH; Kim MS
    Acta Ophthalmol; 2012 Nov; 90(7):e540-6. PubMed ID: 23106861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline inhibits alkali burn-induced corneal neovascularization in mice.
    Xiao O; Xie ZL; Lin BW; Yin XF; Pi RB; Zhou SY
    PLoS One; 2012; 7(7):e41858. PubMed ID: 22848638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasudil hydrochloride, a potent ROCK inhibitor, inhibits corneal neovascularization after alkali burns in mice.
    Zeng P; Pi RB; Li P; Chen RX; Lin LM; He H; Zhou SY
    Mol Vis; 2015; 21():688-98. PubMed ID: 26120273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of NADPH oxidases in alkali burn-induced corneal injury.
    Gu XJ; Liu X; Chen YY; Zhao Y; Xu M; Han XJ; Liu QP; Yi JL; Li JM
    Int J Mol Med; 2016 Jul; 38(1):75-82. PubMed ID: 27221536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model.
    Kim JW; Jeong H; Yang MS; Lim CW; Kim B
    Int Immunopharmacol; 2017 Jul; 48():126-134. PubMed ID: 28501766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK1 receptor antagonists as a new treatment for corneal neovascularization.
    Bignami F; Giacomini C; Lorusso A; Aramini A; Rama P; Ferrari G
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6783-94. PubMed ID: 25228541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of
    Wang YL; Gao GP; Wang YQ; Wu Y; Peng ZY; Zhou Q
    Mol Vis; 2017; 23():286-295. PubMed ID: 28479848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibited experimental mouse corneal neovascularization by CCR3 antagonist].
    Liu G; He X; Zhou W; Xiao Y; Chen Z; Lu P
    Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):285-9. PubMed ID: 24931155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.
    Zuo L; Fan Y; Wang F; Gu Q; Xu X
    Curr Eye Res; 2010 May; 35(5):375-84. PubMed ID: 20450250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of oral doxycycline on neovascularization in a rat corneal alkali burn model of angiogenesis.
    Dan L; Shi-long Y; Miao-li L; Yong-ping L; Hong-jie M; Ying Z; Xiang-gui W
    Curr Eye Res; 2008 Aug; 33(8):653-60. PubMed ID: 18696340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.